The UK Appalachia Community Cancer Network will focus on prevention and early detection of specific cancers with high incidence rates in the region. The network builds on the progress made by a previous program and aims to address the high cancer burden in Appalachian communities.
A recent study, led by Dr. Edward Romond, found that adding trastuzumab to chemotherapy significantly improves prognosis for women with aggressive HER-2 positive breast cancer. The study involved over 3,300 patients and demonstrated substantial benefits of combining trastuzumab with chemotherapy.
A new study published in Arthritis & Rheumatism found that Pfizer's Lyrica significantly reduced pain and improved sleep, fatigue, and other symptoms in patients with fibromyalgia. The study also showed a clinically meaningful reduction of pain in 48% of patients taking Lyrica compared to 27% on placebo.
Joseph L. Fink III has been recognized with the National Pharmacy Leadership Award for his dedication to promoting pharmacist development and leadership qualities among students. He is a prominent figure in pharmacy law and public policy, having served in various roles at the University of Kentucky.
Researchers are developing a vaccine using dendritic cells to boost the immune system against lung cancer recurrence. The study enrolls patients for two years, with promising previous results, aiming to treat 30 new patients.